AssetMark Inc
OM icon

AssetMark Inc’s Outset Medical OM Stock Holding History

AssetMark Inc’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-622
Closed -$50.5K – 2064
2023
Q4 		$50.5K Buy
622
+123
+25% +$10K ﹤0.01% 1162
2023
Q3 		$81.5K Buy
499
+85
+21% +$20.1K ﹤0.01% 1014
2023
Q2 		$136K Buy
414
+98
+31% +$29.9K ﹤0.01% 899
2023
Q1 		$87.1K Buy
316
+45
+17% +$16.5K ﹤0.01% 939
2022
Q4 		$105K Buy
271
+90
+50% +$25.4K ﹤0.01% 908
2022
Q3 		$43K Buy
181
+60
+50% +$16.1K ﹤0.01% 977
2022
Q2 		$27K Buy
121
+96
+384% +$41.3K ﹤0.01% 1059
2022
Q1 		$17K Buy
+25
New +$15K ﹤0.01% 1103

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

AssetMark Inc's OM Position: Q1 2024 in Review

AssetMark Inc sold out of Outset Medical (OM) in Q1 2024, closing a stake of 622 shares — an estimated $50.5K sold.

AssetMark Inc first reported a position in OM in Q1 2022 and held it in 8 quarters. The position peaked at $136K in Q2 2023. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

  • AssetMark Inc reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
  • AssetMark Inc sold 622 Outset Medical shares in Q1 2024, an estimated $50.5K.
  • AssetMark Inc first reported a position in Outset Medical in Q1 2022 and held it in 8 quarters.
  • AssetMark Inc's Outset Medical position peaked at $136K in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on AssetMark Inc's 13F filing for Q1 2024, filed 7 May 2024.